Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
bearish
Sichuan Kelun-Biotech Biopharm
Watchlist
Kelun-Biotech Placement - Recent Run-Up Makes Its Tricky
Equity Capital Markets
362 Views
04 Jun 2025 13:51
Kelun-Biotech Biopharmaceutical Co (Kelun) is looking to raise up to US$200m from a primary placement. In this note, we will talk about the placement and run the deal through our ECM framework.
What is covered in the Full Insight:
Introduction to Kelun-Biotech Placement
Deal Terms and Dynamics
Past Deal Performance
Recent Financial Performance and Approvals
Analyst Framework and Conclusions
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Sichuan Kelun Biotech (6990 HK): Price Surge & Global Index Inclusion
Sichuan Kelun-Biotech Biopharm (6990.HK) Placement - Thoughts The Pipeline and Valuation Outlook
Kelun-Biotech Placement - Recent Run-Up Makes Its Tricky
Kelun-Biotech (6990 HK) - Advancing Next-Generation ADC Therapeutics
Kelun-Biotech (6990 HK) - Long-Acting TSLP MAb Out-Licensed Via NewCo Model
Trending Collections
More »
Index Rebalance
Japan
Event-Driven
South Korea
Tech Hardware and Semiconductor Research
Equity Bottom-Up
Sell / Short Ideas
Unpaywalled Equity-Bottom-Up
India
Unpaywalled Insights
Trending Insights
More »
MV Australia Equal Weight Index Rebalance Preview: Three Potential Deletions in September
Lynch Group (LGL AU): (Another) Clean Offer From TPG
HMM Tender Side Play: Targeting a Basis Squeeze Ahead of Sep Expiry
Pop Mart (9992 HK): Revenue Up by 204%, Margin Up by 17 PPT, 64% Upside
Hang Seng Index (HSI) Outlook Ahead of Sep25 Rebalance
Top Unpaywalled Insights
More »
India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Kelun-Biotech Placement - Recent Run-Up Makes Its Tricky
04 Jun 2025
Kelun-Biotech IPO Lock-Up Expiry - Strong Performance Leaves Pre-IPO Investors with Large Gains
09 Jul 2024
Kelun-Biotech (科伦博泰) IPO: Fairly Valued at Best
28 Jun 2023
Kelun-Biotech (科伦博泰) Pre-IPO: Thoughts on Valuation
08 Jun 2023
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x